Masitinib is an experimental oral therapy for ALS that's aimed at slowing disease progression. AB Science secured insurance ...

The reality of living with ALS is that it affects everyone differently. Our symptoms progress at vastly different rates.

You’d think after nearly 16 years of living with my husband Todd’s ALS, I might want a break from anything related to illness ...

The study found that about one-third of hospitalized ALS patients experienced difficulty swallowing (dysphagia), and these patients had longer hospital stays, higher healthcare costs, and a greater ...

It’s well established that some cases of amyotrophic lateral sclerosis (ALS) are caused by mutations that are inherited from a person’s parents — but a new study shows some cases of sporadic ALS may ...

Targeting fat-destroying enzymes may offer new ALS treatment approaches. A protein called UBQLN2 is key for regulating both ...

Most other pollutants showed no consistent link to ALS, and many findings were not statistically significant. Higher blood ...

Shionogi acquired global rights to Radicava (edaravone) for ALS from Tanabe Pharma. Radicava treats ALS by neutralizing toxic oxygen molecules to slow progression. Shionogi commits to ensuring ...

I felt sad about leaving Todd at home, but travel is not enjoyable nor practical for him at this stage of his ALS progression. I needed a break from the demands of being on duty as his caregiver, but ...

ALS Canada now offers free national virtual counseling, support groups, and resources. Caregivers can access up to four free virtual therapy sessions for mental health support.

The ALS Association is now throwing its full weight behind the newly reintroduced ACT for ALS Reauthorization Act ( H.R. 8205 ), a bipartisan push to ensure that life-extending programs for people ...

New rare genetic variants are linked to ALS, expanding understanding of genetic contributors. About a quarter of ALS cases have an identifiable genetic contributor. Findings support broader use of ...